SpringerLink
Log in

EBV Persistence in Vivo

Invading and Avoiding the Immune Response

  • Chapter
Herpesviruses and Immunity

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

  • 122 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 117.69
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 160.49
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 160.49
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Henle, W., and Henle, G., 1979, Seroepidemiology of the virus, in: The Epstein-Barr Virus (M. A. Epstein and B. G. Achong, eds.), Springer-Verlag, Berlin, pp. 61–78.

    Google Scholar 

  2. Khanna, R., Burrows, S. R., and Moss, D. J., 1995, Immune regulation in Epstein-Barrvirus-associated diseases, Microbiol. Rev. 59:387–405.

    PubMed  CAS  Google Scholar 

  3. Rickinson, A. B., and Kieff, E., 1996, Epstein-Barr virus, in: Virology (B. N. Fields, D. M. Knipe, and P. M. Howley, eds.), Raven Press, New York, pp. 2397–2446.

    Google Scholar 

  4. Sixbey, J. W., Vesterinen, E. H., Nedrud, J. G., Raab, T. N., Walton, L. A., and Pagano, J. S., 1983, Replication of Epstein-Barr virus in human epithelial cells infected in vitro, Nature 306: 480–483.

    Article  PubMed  CAS  Google Scholar 

  5. Rickinson, A. B., 1984, Epstein-Barr virus in epithelium, Nature 310:99–100.

    Article  PubMed  CAS  Google Scholar 

  6. Karajannis, M. A., Hummel, M., Anagnostopoulos, I., and Stein, H., 1997, Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals, Blood 89:2856–2862.

    PubMed  CAS  Google Scholar 

  7. Anagnostopoulos, I., Hummel, M., Kreschel, C., and Stein, H., 1995, Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus, Blood 85:744–750.

    PubMed  CAS  Google Scholar 

  8. Thorley-Lawson, D. A., and Mann, K. P., 1985, Early events in Epstein-Barr virus infection provide a model for B cell activation, J. Exp. Med. 162:45–59.

    Article  PubMed  CAS  Google Scholar 

  9. Thorley-Lawson, D. A., Schooley, R. T., Bhan, A. K., and Nadler, L. M., 1982, Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts, Cell 30:415–425.

    Article  PubMed  CAS  Google Scholar 

  10. Kieff, E., 1996, Epstein-Barr virus and its replication, in: Virology (B. N. Fields, D. M. Knipe, and P. M. Howley, eds.), Raven Press, New York, pp. 2343–2396.

    Google Scholar 

  11. Thorley-Lawson, D. A., and Miyashita, E. M., 1996, Epstein-Barr virus and the B cell: That’s all ittakes, TrendsMicrobial. 4:204–208.

    CAS  Google Scholar 

  12. Nemerow, G. R., Houghten, R. A., Moore, M. D., and Cooper, N. R., 1989, Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2), Cell 56:369–377.

    Article  PubMed  CAS  Google Scholar 

  13. Sinclair, A. J., Palmero, I., Peters, G., and Farrell, P. J., 1994, EBNA-2 and EBNA-LP cooperate to cause GO to GI transition during immortalization of resting human B lymphocytes by Epstein-Barrvirus, EMBO ℑ 13:3321–3328.

    CAS  Google Scholar 

  14. Hurley, E. A., and Thorley-Lawson, D. A., 1988, B cell activation and the establishment of Epstein-Barrvirus latency, ℑ Exp. Med. 168:2059–2075.

    CAS  Google Scholar 

  15. Yates, J. L., Warren, N., and Sugden, B., 1985, Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells, Nature 313:812–815.

    Article  PubMed  CAS  Google Scholar 

  16. Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H., and Farrell, P. J., 1995, Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53, EMBO ℑ 14:1382–1391.

    CAS  Google Scholar 

  17. Allday, M. J., Inman, G. J., Crawford, D. H., and Farrell, P. J., 1995, DNA damage in human B cells can induce apoptosis, proceeding from GI/S when p53 is transactivation competent and G2/M when it is transactivation defective, EMBO ℑ 14:4994–5005.

    CAS  Google Scholar 

  18. Parker, G. A., Crook, T., Bain, M., Sara, E. A., Farrell, P. J., and Allday, M. J., 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7, Oncogene 13:2541–2549.

    PubMed  CAS  Google Scholar 

  19. Horuk, R., 1994, Molecular properties of the chemokine receptor family, Trends Pharm. Sci. 15:159–165.

    Article  PubMed  CAS  Google Scholar 

  20. Mann, K. P., Staunton, D., and Thorley-Lawson, D. A., 1985, Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells, ℑ Virol. 55:710–720.

    CAS  Google Scholar 

  21. Armitage, R. J., 1994, Tumor necrosis factor receptor superfamily members and their ligands, Curr. Opinion Immunol. 6:407–413.

    CAS  Google Scholar 

  22. Baker, S. J., and Reddy, E. P., 1996, Transducers of life and death: TNF receptor superfamily and associated proteins, Oncogene 12:1–9.

    PubMed  CAS  Google Scholar 

  23. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van, K. C., Liu, Y. J., Rousset, F., and Saeland, S., 1994, The CD40 antigen and its ligand, Ann. Rev. Immunol. 12:881–922.

    Article  CAS  Google Scholar 

  24. MacLennan, I. C., 1994, Germinal centers, Ann. Rev. Immunol. 12:117–139.

    Article  CAS  Google Scholar 

  25. Mosialos, G., Birkenbach, M., Yalamanchili, R., Van Arsdale, T., Ware, C., and Kieff, E., 1995, The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family, Cell 80:389–399.

    Article  PubMed  CAS  Google Scholar 

  26. Hammarskjold, M. L., and Simurda, M. C., 1992, Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity, ℑ Virol. 66:6496–6501.

    CAS  Google Scholar 

  27. Sandberg, M., Hammerschmidt, W., and Sugden, B., 1997, Characterization of LMP-1’s association with TRAF1, TRAF2, and TRAF3, J Virol. 71:4649–4656.

    PubMed  CAS  Google Scholar 

  28. Brodeur, S. R., Cheng, G., Baltimore, D., and Thorley-Lawson, D. A., 1997, Localization of the major NF-kappaB-activating site and the sole TR4F3 binding site of LMP-1 defines two distinct signaling motifs [in process citation], ℑ Biol. Chem. 272:19777–19784.

    CAS  Google Scholar 

  29. Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W.,1998, Epstein-Barr virusmediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor, Embo ℑ 17:1700–1709.

    Google Scholar 

  30. Hammerschmidt, W., and Sugden, B., 1989, Genetic analysis of immortalizing functions of Epstein-Barrvirus in human B lymphocytes, Nature 340:393–397.

    Article  PubMed  CAS  Google Scholar 

  31. Artavanis-Tsakonas, S., Matsuno, K., and Fortini, M. E., 1995, Notch signaling, Science 268:225–232.

    PubMed  CAS  Google Scholar 

  32. Hsieh, J. J., Henkel, T., Salmon, P., Robey, E., Peterson, M. G., and Hayward, S. D., 1996, Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barrvirus EBNA2, Mol. Cell. Biol. 16:952–959.

    PubMed  CAS  Google Scholar 

  33. MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., and Zlotnik, A., 1990, IL-10, a novel growth cofactor for mature and immature T cells, ℑ Immunol. 145:4167–4173.

    CAS  Google Scholar 

  34. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E., 1991, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, ℑ Exp. Med. 174:915–924.

    Google Scholar 

  35. Stuart, A. D., Stewart, J. P., Arrand, J. R., and Mackett, M., 1995, The Epstein-Barr virus encoded cytokine viral interleukin-IO enhances transformation of human B lymphocytes, Oncogene 11:1711–1719.

    PubMed  CAS  Google Scholar 

  36. Ianelli, C. J., DeLellis, R., and Thorley-Lawson, D. A., 1998, CD 48 binds to heparan sulfate on the surface of epithelial cells, ℑ Biol. Chem. 273.

    Google Scholar 

  37. Gallagher, J. T., 1994, Heparan sulphates as membrane receptors for the fibroblast growth factors, Eur. ℑ Clin. Chem. Clin. Biochem. 32:239–247.

    CAS  Google Scholar 

  38. Sutkowski, N., Palkama, T., Gong, Y., Ciurli, C., Sekaly, R., Thorley-Lawson, D. A., and Huber, B. T., 1996, An Epstein-Barrvirus associated superantigen, ℑ Exp. Med. 184:971–980.

    CAS  Google Scholar 

  39. Huber, B. T., Hsu, P. N., and Sutkowski, N., 1996, Virus encoded superantigens, Microbiol. Rev. 60:473–482.

    PubMed  CAS  Google Scholar 

  40. Robinson, J., Smith, D., and Niederman, J., 1980, Mitotic EBSA-positive lymphocytes in peripheral blood during infectious mononucleosis, Nature 287:334–335.

    PubMed  CAS  Google Scholar 

  41. Tierney, R. J., Steven, N., Young, L. S., and Rickinson, A. B., 1994, Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state, J. Virol. 68:7374–7385.

    PubMed  CAS  Google Scholar 

  42. Bourgault, I., Gomez, A., Gomard, E., and Levy, J. P., 1991, Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barrvirus-specific cytolytic T lymphocytes, Clin. Exp. Immunol. 84:501–507.

    PubMed  CAS  Google Scholar 

  43. Khanna, R., Slade, R. W., Poulsen, L., Moss, D. J., Burrows, S. R., Nicholls, J., and Burrows, J. M., 1997, Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: Evidence for immune pressure-independent genetic drift, ℑ Virol. 71:8340–8346.

    CAS  Google Scholar 

  44. Phillips, R. E., Rowland-dones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R., Rizza, C. R. et al., 1991, Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition, Nature 354:453–459.

    Article  PubMed  CAS  Google Scholar 

  45. Miyashita, E. M., Yang, B., Lam, K. M., Crawford, D. H., and Thorley-Lawson, D. A., 1995, A novel form of Epstein-Barr virus latency in normal B cells in vivo, Cell 80:593–601.

    Article  PubMed  CAS  Google Scholar 

  46. Miyashita, E. M., Yang, B., Babcock, G. J., and Thorley-Lawson, D. A., 1997, Identification of the site of Epstein-Barrvirus persistence in vivo as a resting B cell, ℑ Virol. 71:4882–4891.

    CAS  Google Scholar 

  47. Decker, L. L., Klaman, L. D., and Thorley-Lawson, D. A., 1996, Detection of the latent form of Epstein-Barrvirus DNA in the peripheral blood of healthy individuals, ℑ Virol. 70:3286–3289.

    CAS  Google Scholar 

  48. Babcock, G. J., Decker, L. L., Volk, M., and Thorley-Lawson, D. A., 1998, EBV Persistence in Memory B cells in vivo, Immunity 8.

    Google Scholar 

  49. Chen, F., Zou, J. Z., di Renzo, L., Winberg, G., Hu, L. F., Klein, E., Klein, G., and Ernberg, I., 1995, A subpopulation of normal B cells latently infected with Epstein-Barrvirus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1, ℑ Virol 69:3752–3758.

    CAS  Google Scholar 

  50. Qu, L., and Rowe, D. T., 1992, Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes, ℑ Virol. 66:3715–3724.

    CAS  Google Scholar 

  51. Beaufils, P., Choquet, D., Mamoun, R. Z., and Malissen, B., 1993, The (YXXL/I)2 signaling motif found in the cytoplasmic segments of the bovine leukemia virus envelope protein and Epstein-Barr latent membrane protein 2A can elicit early and late lymphocyte activation events, EA4BOℑ 12:5105–5112.

    CAS  Google Scholar 

  52. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B., and Kieff, E., 1995, Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases, Immunity 2: 155–166.

    Article  PubMed  CAS  Google Scholar 

  53. Khan, G., Miyashita, E. M., Yang, B., Babcock, G. J., and Thorley-Lawson, D. A., 1996, Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5:173–179.

    Article  PubMed  CAS  Google Scholar 

  54. Ahmed, R., and Gray, D., 1996, Immunological memory and protective immunity: Understanding their relation, Science 272:54–60.

    PubMed  CAS  Google Scholar 

  55. Tough, D. F., and Sprent, J., 1995, Lifespan of lymphocytes, Immunol. Res. 14:1–12.

    Article  PubMed  CAS  Google Scholar 

  56. Arpin, C., Dechanet, J., Van, K. C., Merville, P., Grouard, G., Briere, F., Banchereau, J., and Liu, Y. J., 1995, Generation of memory B cells and plasma cells in vitro, Science 268:720–722.

    PubMed  CAS  Google Scholar 

  57. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald, M. P., Klein, G., Kurilla, M. G., and Masucci, M. G., 1995, Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-I, Nature 375:685–688.

    Article  PubMed  CAS  Google Scholar 

  58. Tsai, C. N., Liu, S. T., and Chang, Y. S.,1995, Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene, DNA Cell Biol. 14:767–776.

    Google Scholar 

  59. Schaefer, B. C., Strominger, J. L., and Speck, S. H., 1995, Redefining the Epstein-Barr virusencoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565–10569.

    PubMed  CAS  Google Scholar 

  60. Sung, N. S., Wilson, J., Davenport, M. Sista, N. D., and Pagano, J. S., 1994, Reciprocal regulation of the Epstein-Barrvirus BamHI-F promoter by EBNA-1 and an E2F transcription factor, Mol. Cell. Biol. 14:7144–7152.

    PubMed  CAS  Google Scholar 

  61. Nonkwelo, C., Ruf, I. K., and Sample, J., 1997, The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element, ℑ Virol. 71:354–361.

    CAS  Google Scholar 

  62. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H., and Lanier, L. L., 1992, CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes, ℑ Exp. Med. 175:353–360.

    CAS  Google Scholar 

  63. Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., and Pardoll, D. M., 1995, A reassessment of the role of B7-1 expression in tumor rejection, ℑ Exp. Med. 182:1415–1421.

    CAS  Google Scholar 

  64. di Renzo, L., Altiok, A., Klein, G., and Klein, E., 1994, Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. Int. J Canc. 57:914–919.

    Article  Google Scholar 

  65. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A., 1993, Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death, Proc. Natl. Acad. Sci. USA 90:8479–8483.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departmentof Pathology, Tufts University School of Medicine, Boston, Massachusetts, 021 1 1

    Davida Thorley-Lawson

Authors
  1. Davida Thorley-Lawson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Peter G. Medveczky  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Thorley-Lawson, D. (2002). EBV Persistence in Vivo . In: Medveczky, P.G., Friedman, H., Bendinelli, M. (eds) Herpesviruses and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46808-5_9

Download citation

  • DOI: https://doi.org/10.1007/0-306-46808-5_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45890-3

  • Online ISBN: 978-0-306-46808-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation